Cargando…

MON-093 Myokine Levels after Resistance Exercise in Young Adults with Prader-Willi Syndrome (PWS)

Background: Individuals with PWS require marked caloric restriction and daily exercise to prevent morbid obesity. Lower energy expenditure compared to BMI-matched controls along with hypotonia, decreased muscle mass, and cognitive impairment make exercise particularly challenging for this population...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirsch, Harry, Gross-Tsur, Varda, Sabag, Yanir, Pollak, Yehuda, Nice, Shachar, Genstil, Larry, Benarroch, Fortu, Constantini, Naama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adipose Tissue, Appetite, and Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550927/ http://dx.doi.org/10.1210/js.2019-MON-093

Ejemplares similares

The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction
por: Gross-Tsur, Varda, et al.
Publicado: (2012)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome
por: Hirsch, Harry J., et al.
Publicado: (2015)

ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison
por: Barclay, Sarah F., et al.
Publicado: (2018)

SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020)

SUN-595 Comparative Comorbidity Burden Among Patients with Prader-Willi Syndrome: A Population-Level Cohort Study
por: Stafford, Diane E J, et al.
Publicado: (2020)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

OR10-2 Hormonal and Cardiometabolic Changes Associated with Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome
por: Abuzzahab, Jennifer, et al.
Publicado: (2022)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

SUN-597 Healthcare Utilization Patterns Among Commercially Insured Patients with Prader-Willi Syndrome: A Retrospective Analysis of Administrative Claims
por: Butler, Merlin G, et al.
Publicado: (2020)

RF24 | PSUN94 Long-Term Safety of Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome
por: Woloschak, Michael, et al.
Publicado: (2022)

Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
por: Schwartz, Lauren, et al.
Publicado: (2021)

SUN-093 Early Life Exposure to High Fat Diet Induces Extensive Changes in the Adult Brain
por: Roy, Anna, et al.
Publicado: (2019)

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

Topline Results of the CARE-PWS Phase 3 Study: Intranasal Carbetocin Improves Hyperphagia and Anxiety and Distress Symptoms in Prader-Willi Syndrome (PWS)
por: Ryman, Davis, et al.
Publicado: (2021)

SAT-093 Effect of HIV Infection and Antiretroviral Therapy Use on Body Weight and Body Weight Changes over a 5-Year Period in US Veterans
por: Garcia, Jose, et al.
Publicado: (2019)

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
por: Allas, Soraya, et al.
Publicado: (2019)

Suicidality and Self-Harming Behaviors in Patients with Prader-Willi Syndrome (PWS): Case Report and Literature Review
por: Bellman, Val, et al.
Publicado: (2021)

Case report: severe asymptomatic hyponatremia in Prader-Willi Syndrome
por: Landau, Daniel, et al.
Publicado: (2016)

Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
por: Roof, Elizabeth, et al.
Publicado: (2023)

Growth hormone treatment for adults with Prader-Willi syndrome: another point of view
por: Hirsch, Harry J., et al.
Publicado: (2021)

Patients with mosaic methylation patterns of the Prader-Willi/Angelman Syndrome critical region exhibit AS-like phenotypes with some PWS features
por: Aypar, Umut, et al.
Publicado: (2016)

SAT-380 Screening for Central Adrenal Insufficiency in Children with Prader-Willi Syndrome (PWS) with Single Collection Of ACTH and Cortisol Levels
por: Angulo, Moris, et al.
Publicado: (2019)

Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader–Willi syndrome
por: Knani, Ibrahim, et al.
Publicado: (2016)

A Special, Strict, Fat-Reduced, and Carbohydrate-Modified Diet Leads to Marked Weight Reduction even in Overweight Adolescents with Prader-Willi Syndrome (PWS)
por: Bonfig, Walter, et al.
Publicado: (2009)

Incomplete methylation of a germ cell tumor (Seminoma) in a Prader‐Willi male
por: Eldar‐Geva, Talia, et al.
Publicado: (2018)

Three Siblings with Prader-Willi Syndrome: Brief Review of Sleep and Prader-Willi Syndrome
por: Bingeliene, Arina, et al.
Publicado: (2015)

Genetics of Prader-Willi syndrome and Prader-Will-Like syndrome
por: Cheon, Chong Kun
Publicado: (2016)

Epigenetics in Prader-Willi Syndrome
por: Mendiola, Aron Judd P., et al.
Publicado: (2021)

Prader-Willi Syndrome: Clinical Aspects
por: Elena, Grechi, et al.
Publicado: (2012)

Hyperprolactinemia in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021)

Approach to the Patient With Prader–Willi Syndrome
por: Höybye, Charlotte, et al.
Publicado: (2022)

Sleep Consequences of Prader-Willi Syndrome
por: Itani, Reem, et al.
Publicado: (2023)

Causes of Death in Prader-Willi Syndrome: Prader-Willi Syndrome Association (USA) 40-Year Mortality Survey
por: Butler, Merlin G., et al.
Publicado: (2016)

Distinct promoter regions of the oxytocin receptor gene are hypomethylated in Prader-Willi syndrome and in Prader-Willi syndrome associated psychosis
por: Heseding, Hannah M., et al.
Publicado: (2022)

Prader-Willi syndrome: A primer for clinicians
por: Cataletto, Mary, et al.
Publicado: (2011)

Prader-Willi Syndrome and Growth Hormone Deficiency
por: Aycan, Zehra, et al.
Publicado: (2014)

Endocrine manifestations and management of Prader-Willi syndrome
por: Emerick, Jill E, et al.
Publicado: (2013)

Clinical and laboratory characteristics of Prader-Willi syndrome
por: Thao, Bui Phuong, et al.
Publicado: (2013)

Gall bladder agenesis in Prader Willi syndrome
por: Nair, Abilash, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8rue62rgscd2ma5ftpgr0clha0